http://akprabhakar.blogspot.com/2009/12/banking-stocks-look-negative.html BSEBANKEX (9991) after making high of 10698 for 2009, now the sector looks weak below 9900 correction till 9500 can be considered healthy below which caution advised as advance tax figures which is source based point to negative to flat tax payment with no major surprise now.
*2Day seminar in Delhi on 9th & 10th January 2010 on Techno-Fundamental details below* http://navneetsinghal.blogspot.com/2009/12/seminar-jan-2010-details.html2Days Seminar on Techno-Fundamental Conducted by A.K.Prabhakar in association with CA. Navneet Singhal Contact Mr.Navneet for bookings Mobile number-09899593340 [email protected] Date & Time:-9 th Jan 2010 9:30 AM to 5:00 PM- 10 th Jan 2010 9:30 AM to 2:30 PM Venue :- The Saffron Court, Convocation Hall, 8, Sikka Trade Complex, L.S.C. New Rajdhani Enclave, Vikas Marg, Delhi-92 (Near preet vihar Metro station). *Glenmark Pharmaceuticals* Ltd may settle with US firm Merck/Schering Plough Pharmaceuticals Llc, resulting in the with drawal of patent litigations related to the launch of a copy of the latter's $1.6 billion (Rs7,472 crore) in sales drug ezetimibe in the US market next year, according to a report released by First Global Securities Ltd last week. If successful, the Indian company will be able to grab a significant share in the US of the sales of the world's fourthmost prescribed anticholester ol drug because it will then become the only firm to sell a lowcost version of it in the first six months of the launch. Merck sells this drug under the brand name Zetia. Regards A.K.Prabhakar Equity Analyst [email protected] [email protected] * * http://akprabhakar.blogspot.com http://prabhakar-views.blogspot.com *Disclaimer:*** *This represents views based purely on Technical studies. The information and views presented in this report are prepared by A K Prabhakar. The information contained herein is based on my analysis of the Charts and upon sources that I consider reliable. I, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and I am not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither A K Prabhakar nor any person connected with him accepts any liability arising from the use of this information and views mentioned in this document. A K Prabhakar and his affiliates may hold long or short positions in the above-mentioned companies from time to time. The report is intended for a restricted audience and I am not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities. * -- You received this message because you are subscribed to the Google Groups ""GLOBAL SPECULATORS"" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/globalspeculators?hl=en.
